Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3L6R

The structure of mammalian serine racemase: Evidence for conformational changes upon inhibitor binding

Summary for 3L6R
Entry DOI10.2210/pdb3l6r/pdb
Related3HMK 3L6B 3L6C
DescriptorSerine racemase, MALONATE ION, MANGANESE (II) ION, ... (4 entities in total)
Functional Keywordspyridoxal phosphate, plp, serine racemase, isomerase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight38075.43
Authors
Smith, M.A.,Mack, V.,Ebneth, A.,Cesura, A.,Felicetti, B.,Barker, J. (deposition date: 2009-12-24, release date: 2010-01-26, Last modification date: 2021-11-10)
Primary citationSmith, M.A.,Mack, V.,Ebneth, A.,Moraes, I.,Felicetti, B.,Wood, M.,Schonfeld, D.,Mather, O.,Cesura, A.,Barker, J.
The structure of mammalian serine racemase: evidence for conformational changes upon inhibitor binding.
J.Biol.Chem., 285:12873-12881, 2010
Cited by
PubMed Abstract: Serine racemase is responsible for the synthesis of D-serine, an endogenous co-agonist for N-methyl-D-aspartate receptor-type glutamate receptors (NMDARs). This pyridoxal 5'-phosphate-dependent enzyme is involved both in the reversible conversion of L- to D-serine and serine catabolism by alpha,beta-elimination of water, thereby regulating D-serine levels. Because D-serine affects NMDAR signaling throughout the brain, serine racemase is a promising target for the treatment of disorders related to NMDAR dysfunction. To provide a molecular basis for rational drug design the x-ray crystal structures of human and rat serine racemase were determined at 1.5- and 2.1-A resolution, respectively, and in the presence and absence of the orthosteric inhibitor malonate. The structures revealed a fold typical of beta-family pyridoxal 5'-phosphate enzymes, with both a large domain and a flexible small domain associated into a symmetric dimer, and indicated a ligand-induced rearrangement of the small domain that organizes the active site for specific turnover of the substrate.
PubMed: 20106978
DOI: 10.1074/jbc.M109.050062
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.7 Å)
Structure validation

235458

PDB entries from 2025-04-30

PDB statisticsPDBj update infoContact PDBjnumon